Biotie Therapies Stocks List Ranked for 2024 |

Symbol	Grade	Name	% Change
LXRX	F	Lexicon Pharmaceuticals, Inc.	11.88
CANF	F	Can-Fite Biopharma Ltd Sponsored ADR (Israel)	-0.51
VTVT	D	vTv Therapeutics Inc.	-4.38

Related Industries: Biotechnology

Symbol	Grade	Name	Weight
BBP	C	BioShares Biotechnology Products Fund	0.74
QQQS	B	Invesco NASDAQ Future Gen 200 ETF	0.27
IWC	B	iShares Microcap ETF	0.04
IBBQ	F	Invesco Nasdaq Biotechnology ETF	0.04
TXSS	A	Texas Small Cap Equity Index ETF	0.04

Compare ETFs

Compare BBP to QQQS Compare IWC to TXSS Compare QQQS to IWC

Date	Stock	Title
Nov 22	LXRX	Lexicon Pharmaceuticals to Cut 60% of Workforce
Nov 22	LXRX	Lexicon falls on restructuring program
Nov 22	LXRX	Lexicon to Reposition as Clinical Development-Focused Company Following Regulatory Update From FDA
Nov 22	LXRX	Lexicon to disband sales team, lay off 60% of staff
Nov 20	LXRX	Lexicon Appoints Ivan H. Cheung to Board of Directors
Nov 18	LXRX	Lexicon Pharmaceuticals (NASDAQ:LXRX investor three-year losses grow to 80% as the stock sheds US$107m this past week
Nov 17	VTVT	vTv Therapeutics (NASDAQ:VTVT) adds US$9.5m to market cap in the past 7 days, though investors from five years ago are still down 71%

Biotie Therapies: Biotie Therapies was a Finnish biotechnology and pharmaceutics company that was acquired by Acorda Therapeutics in January 2016. The company's research and development was focused on drugs for neurodegenerative and psychiatric disorders like Parkinson's disease, Alzheimer's disease and other cognitive disorders, alcohol and drug dependence and post traumatic stress disorder, and inflammatory and fibrotic liver disease. The company's headquarters is in Turku, Western Finland, and it is listed on NASDAQ OMX Helsinki.